Marsh, David C.

Testosterone suppression in opioid users: A systematic review and meta-analysis

Bawor, M., Bami, H., Dennis, B. B., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Steiner, M., Anglin, R., et al. (2015) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentHormonal and reproductive studies

Cited by 123

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users

Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004) · Harm Reduction Journal

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 107

Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population‐based retrospective cohort study

Nosyk, B., Sun, H., Evans, E., Marsh, D. C., Anglin, M. D., Hser, Y., & Anis, A. H. (2012) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 81

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

Franklyn, A. M., Eibl, J. K., Gauthier, G., Pellegrini, D., Lightfoot, N. E., & Marsh, D. C. (2017) · Harm Reduction Journal

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 39

Patient-centred care for addiction treatment: a scoping review protocol

Marchand, K., Beaumont, S., Westfall, J., MacDonald, S., Harrison, S., Marsh, D. C., Schechter, M. T., & Oviedo-Joekes, E. (2018) · BMJ Open

Substance Abuse Treatment and OutcomesMental Health and Patient Involvement

Cited by 28